Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

KALA

KALA BIO (KALA)

KALA BIO Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:KALA
日付受信時刻ニュースソース見出しコード企業名
2024/03/2921 : 00GlobeNewswire Inc.KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
2024/03/0421 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
2024/02/2622 : 00GlobeNewswire Inc.KALA BIO to Present at TD Cowen 44th Annual Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
2024/02/1503 : 09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KALAKALA BIO Inc
2024/02/0622 : 00GlobeNewswire Inc.KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:KALAKALA BIO Inc
2024/01/2006 : 01GlobeNewswire Inc.KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
2024/01/0606 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
2024/01/0606 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
2024/01/0606 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
2024/01/0606 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
2023/12/2222 : 22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
2023/11/1322 : 10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KALAKALA BIO Inc
2023/11/1322 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
2023/11/1322 : 00GlobeNewswire Inc.KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
2023/10/1905 : 04Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:KALAKALA BIO Inc
2023/09/2105 : 01GlobeNewswire Inc.KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
2023/09/0521 : 00GlobeNewswire Inc.KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:KALAKALA BIO Inc
2023/08/0421 : 00GlobeNewswire Inc.KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
2023/08/0305 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
2023/08/0305 : 01GlobeNewswire Inc.KALA BIO to Participate in Upcoming Investor Conferences in AugustNASDAQ:KALAKALA BIO Inc
2023/08/0221 : 00GlobeNewswire Inc.Kala Pharmaceuticals Announces Name Change to KALA BIONASDAQ:KALAKALA BIO Inc
2023/07/2005 : 01GlobeNewswire Inc.Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
2023/06/2405 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
2023/06/2405 : 01GlobeNewswire Inc.Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
2023/06/2305 : 48Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KALAKALA BIO Inc
2023/06/1600 : 58Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KALAKALA BIO Inc
2023/06/0221 : 00GlobeNewswire Inc.Kala Pharmaceuticals to Present at the Jefferies Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
2023/06/0105 : 03Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:KALAKALA BIO Inc
2023/05/1206 : 26Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KALAKALA BIO Inc
2023/05/0921 : 00GlobeNewswire Inc.Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
 Showing the most relevant articles for your search:NASDAQ:KALA

最近閲覧した銘柄